These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6394347)

  • 1. Systemic and cardiac haemodynamic interactions between guanfacine and hydrallazine in hypertensive patients.
    Velasco M; Urbina-Quintana A; Morillo J; Vizcarrondo H; Ramirez A; Hernández E; Hernández-Pieretti O
    Eur J Clin Pharmacol; 1984; 27(4):393-6. PubMed ID: 6394347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic effects of guanfacine in essential hypertension.
    Feldstein CA; Cohen AA; Sabaris RP; Burucúa JE
    Clin Ther; 1984; 6(3):325-34. PubMed ID: 6373009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic and endocrine responses to guanfacine in normotensive volunteers and hypertensive patients.
    Rosenthal JH
    Am J Cardiol; 1986 Mar; 57(9):22E-26E. PubMed ID: 3513526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Blood pressure and renin under treatment of hypertension with guanfacine (author's transl)].
    Rosenthal J; Jäger H
    MMW Munch Med Wochenschr; 1980 Jan; 122(4):137-40. PubMed ID: 6767938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of long-term treatment of essential hypertension with guanfacine.
    Higuchi M; Overlack A; Stumpe KO
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):61S-64S. PubMed ID: 6994780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hypotensive and hemodynamic effects of guanfacine in arterial hypertension].
    Erina EV; Beliakova EV; Charyev KhZ; Panfilov VV
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1989; 12(1):63-7. PubMed ID: 2663029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guanfacine in essential hypertension: effect on blood pressure, plasma noradrenaline concentration and plasma renin activity.
    Schoeppe W; Brecht HM
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):97S-101S. PubMed ID: 6994788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic effects of loud noise before and after central sympathetic nervous stimulation.
    Eggertsen R; Svensson A; Magnusson M; Andrén L
    Acta Med Scand; 1987; 221(2):159-64. PubMed ID: 2884813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of propranolol on sympathetic nervous activity in hydrallazine-treated hypertensive patients.
    Velasco M; Romero E; Bertoncini H; Urbina-Quintana A; Guevara J; Hernández-Pieretti O
    Br J Clin Pharmacol; 1978 Sep; 6(3):217-20. PubMed ID: 687499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of guanfacine on blood pressure and renin activity in hypertensive patients.
    Rosenthal J
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):91S-96S. PubMed ID: 6994787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sympathetic reflex responses during treatment of essential hypertension with hydrallazine and oxprenolol.
    Davies IB; Sever PS; Rosenthal T
    Br J Clin Pharmacol; 1979 Jul; 8(1):49-51. PubMed ID: 399592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemodynamics in hypertensive patients before and during guanfacine treatment.
    Schäfer N; Rauh J; Rosenthal J
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):133S-135S. PubMed ID: 6994767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of guanfacine monotherapy on blood pressure, heart rate, plasma renin activity, aldosterone, and catecholamines in hypertensive patients with chronic glomerulonephritis.
    Ikeda T; Gomi T; Yuhara M; Sakurai J; Nakayama D
    Clin Pharmacol Ther; 1988 Mar; 43(3):278-82. PubMed ID: 3278821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationships between blood pressure, heart rate and plasma epinephrine, norepinephrine, angiotensin II concentrations, plasma renin activity during chronic guanfacine therapy in patients with essential arterial hypertension.
    Collart F; Staroukine M; Verniory A
    Acta Cardiol; 1985; 40(3):269-76. PubMed ID: 3895792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of guanfacine on growth hormone, prolactin, renin, lipoproteins and glucose in essential hypertension.
    Hauger-Klevene JH; Balossi EC; Scornavacchi JC
    Am J Cardiol; 1986 Mar; 57(9):27E-31E. PubMed ID: 3513527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guanfacine: effects of long-term treatment and withdrawal.
    Reid JL; Zamboulis C; Hamilton CA
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):183S-188S. PubMed ID: 6994774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of chronic guanfacine administration on high plasma vasopressin levels in essential hypertension.
    Berkman K; Tözün N; Taga Y; Dedeoğlu A; Onat F; Bekiroğlu N
    Int J Clin Pharmacol Ther Toxicol; 1990 Feb; 28(2):67-71. PubMed ID: 2407671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A postmarketing evaluation of guanfacine hydrochloride in mild to moderate hypertension.
    Board AW; Perry VP; Shepperson BE; Nyman CE; Carchman SH
    Clin Ther; 1988; 10(6):761-75. PubMed ID: 3064907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of clonidine and guanfacine in essential hypertension.
    Farsang C; Varga K; Vajda L; Alföldi S; Kapocsi J
    Clin Pharmacol Ther; 1984 Nov; 36(5):588-94. PubMed ID: 6386275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Haemodynamic investigations with the new antihypertensive drug guanfacine (author's transl)].
    Rosenthal J; Schäfer N; Rauh J; Raschig A
    Dtsch Med Wochenschr; 1980 Nov; 105(48):1680-4. PubMed ID: 7002524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.